TickerFacts.

Baird Medical Investment Holdings Ltd (BDMD): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$24.53M
Year ended 2025-12-31
$16.45M2022-12-31: $14.55M2023-12-31: $12.88M2024-12-31: $16.45M2025-12-31: -$24.53M-$24.53M
2022-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$24.53Mn/m2026-07-27, From 2025-01-01
2024-12-31$16.45M+27.8%2026-07-27, From 2024-01-01
2023-12-31$12.88M-11.5%2026-07-27, From 2023-01-01
2022-12-31$14.55Mn/a2025-05-15, From 2022-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31-$24.53Mn/m
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31-$2.32Mn/m
Nephros Inc (NEPH)2025-12-31$1.29M+812.1%
Sensus Healthcare, Inc. (SRTS)2025-12-31-$9.91Mn/m
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$18.59Mn/m
Premier Air Charter Holdings Inc. (PREM)2025-12-31-$1.95Mn/m
Allurion Technologies, Inc. (ALUR)2025-12-31-$29.17Mn/m
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31-$51.48Mn/m
ClearPoint Neuro, Inc. (CLPT)2025-12-31-$23.35Mn/m

Compare BDMD, SNOA, NEPH, SRTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗